Bob D. Rush

943 total citations
21 papers, 663 citations indexed

About

Bob D. Rush is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bob D. Rush has authored 21 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bob D. Rush's work include Neuropeptides and Animal Physiology (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Receptor Mechanisms and Signaling (4 papers). Bob D. Rush is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Receptor Mechanisms and Signaling (4 papers). Bob D. Rush collaborates with scholars based in United States, Poland and Germany. Bob D. Rush's co-authors include Mary J. Ruwart, Karen F. Wilkinson, Thomas J. Vidmar, Philip S. Burton, Keith S. Henley, Henry D. Appelman, Gordon L. Bundy, Jed F. Fisher, Allen W. Harrison and Alan S. Nies and has published in prestigious journals such as Hepatology, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Bob D. Rush

21 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bob D. Rush United States 14 200 169 155 152 116 21 663
Isao Yamatsu Japan 14 258 1.3× 117 0.7× 136 0.9× 72 0.5× 74 0.6× 51 834
A Szewczuk Poland 16 478 2.4× 233 1.4× 102 0.7× 203 1.3× 57 0.5× 79 1.1k
Mary J. Ruwart United States 21 371 1.9× 173 1.0× 263 1.7× 236 1.6× 187 1.6× 64 1.3k
M Armstrong United States 9 204 1.0× 156 0.9× 35 0.2× 257 1.7× 40 0.3× 11 651
Stéphane Dhalluin France 11 341 1.7× 72 0.4× 233 1.5× 92 0.6× 203 1.8× 19 919
Teija Oinonen Finland 13 282 1.4× 96 0.6× 233 1.5× 117 0.8× 100 0.9× 19 699
Sophie Regan United Kingdom 10 160 0.8× 75 0.4× 288 1.9× 84 0.6× 124 1.1× 14 615
Paola Gnocchi Italy 15 204 1.0× 98 0.6× 183 1.2× 71 0.5× 23 0.2× 19 819
M. S. Anwer United States 18 267 1.3× 210 1.2× 168 1.1× 645 4.2× 126 1.1× 58 1.0k
B. O. Depelchin Belgium 6 266 1.3× 46 0.3× 176 1.1× 88 0.6× 169 1.5× 7 714

Countries citing papers authored by Bob D. Rush

Since Specialization
Citations

This map shows the geographic impact of Bob D. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob D. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob D. Rush more than expected).

Fields of papers citing papers by Bob D. Rush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob D. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob D. Rush. The network helps show where Bob D. Rush may publish in the future.

Co-authorship network of co-authors of Bob D. Rush

This figure shows the co-authorship network connecting the top 25 collaborators of Bob D. Rush. A scholar is included among the top collaborators of Bob D. Rush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob D. Rush. Bob D. Rush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larsen, Scott D., Zhi‐Jun Zhang, Peter R. Manninen, et al.. (2007). 7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: Synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase. Bioorganic & Medicinal Chemistry Letters. 17(14). 3840–3844. 8 indexed citations
2.
Brideau, Roger J., Mary L. Knechtel, Audris Huang, et al.. (2002). Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses. Antiviral Research. 54(1). 19–28. 61 indexed citations
3.
Wilkinson, Karen F., Bob D. Rush, Satish Kumar Sharma, et al.. (1993). Development of Activity Assays for High-Volume Evaluation of Human Immunodeficiency Virus (HIV) Protease Inhibitors in Rat Serum: Results with Ditekiren. Pharmaceutical Research. 10(4). 562–566. 2 indexed citations
4.
Sheehy, Ann M., Jennifer L. Hoover, Bob D. Rush, et al.. (1993). Intrapulmonary Delivery of Renin Inhibitory Peptides Results in Sustained Release Because of Saturable Transport. Pharmaceutical Research. 10(10). 1548–1551. 5 indexed citations
5.
Ruwart, Mary J., Roger R. Hinshaw, Karen F. Wilkinson, et al.. (1993). Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities. Journal of Medicinal Chemistry. 36(17). 2575–2577. 23 indexed citations
6.
Conradi, Robert A., Karen F. Wilkinson, Bob D. Rush, et al.. (1993). In Vitro/in Vivo Models for Peptide Oral Absorption: Comparison of Caco-2 Cell Permeability with Rat Intestinal Absorption of Renin Inhibitory Peptides. Pharmaceutical Research. 10(12). 1790–1792. 44 indexed citations
7.
Kolars, Joseph C., Philip L. Stetson, Bob D. Rush, et al.. (1992). CYCLOSPORINE METABOLISM BY P450IIIA IN RAT ENTEROCYTES—ANOTHER DETERMINANT OF ORAL BIOAVAILABILITY?. Transplantation. 53(3). 596–601. 60 indexed citations
8.
Hoover, Jennifer L., Bob D. Rush, Karen F. Wilkinson, et al.. (1992). Peptides are better absorbed from the lung than the gut in the rat.. Pharmaceutical Research. 9(8). 1103–1106. 26 indexed citations
9.
Rush, Bob D., et al.. (1991). Desolvation energy: a major determinant of absorption, but not clearance, of peptides in rats.. Pharmaceutical Research. 8(12). 1477–1481. 40 indexed citations
10.
Fisher, Jed F., Allen W. Harrison, Gordon L. Bundy, et al.. (1991). Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties. Journal of Medicinal Chemistry. 34(10). 3140–3143. 91 indexed citations
11.
Ruwart, Mary J., Satish Kumar Sharma, Douglas W. Harris, et al.. (1990). Development of a Sensitive Activity Assay for High-Volume Evaluation of Human Renin Inhibitory Peptides in Rat Serum: Results with U-71,038. Pharmaceutical Research. 7(4). 407–410. 7 indexed citations
12.
Ruwart, Mary J., Karen F. Wilkinson, Bob D. Rush, et al.. (1989). The Integrated Value of Serum Procollagen Iii Peptide Over Time Predicts Hepatic Hydroxyproline Content and Stainable Collagen in A Model of Dietary Cirrhosis in the Rat. Hepatology. 10(5). 801–806. 87 indexed citations
13.
Ruwart, Mary J., et al.. (1988). 16,16-dimethyl prostaglandin E2 delays collagen formation in nutritional injury in rat liver†. Hepatology. 8(1). 61–64. 50 indexed citations
14.
15.
Rush, Bob D., Mary J. Ruwart, Bradley D. Anderson, & William I. Higuchi. (1985). Evaluation of Lincomycin as a Cholesterol Gallstone Dissolution Rate Accelerator. Journal of Pharmaceutical Sciences. 74(6). 621–624. 1 indexed citations
16.
Ruwart, Mary J. & Bob D. Rush. (1984). The effects of PGF1α, PGE2 and 16,16 dimethyl PGE2 on gastric emptying and small intestinal transit in rat. Prostaglandins. 28(6). 915–928. 16 indexed citations
17.
Rush, Bob D. & Mary J. Ruwart. (1984). The role of accelerated colonic transit in prostaglandin‐induced diarrhoea and its inhibition by prostacyclin. British Journal of Pharmacology. 83(1). 157–159. 12 indexed citations
18.
Ruwart, Mary J., M.S. Klepper, & Bob D. Rush. (1980). Adrenergic and cholinergic contributions to decreased gastric emptying, small intestinal transit, and colonic transit in the postoperative ileus rat. Journal of Surgical Research. 29(2). 126–134. 13 indexed citations
19.
Rush, Bob D., et al.. (1979). A Simple Individualized Method for Dose-Responslve Heparin and Protamine Administration. Journal of ExtraCorporeal Technology. 11(2). 56–60. 1 indexed citations
20.
Nies, Alan S., et al.. (1976). Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat. Biochemical Pharmacology. 25(17). 1991–1993. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isao Yamatsu Breakdown of academic impact, for papers by A Szewczuk Breakdown of academic impact, for papers by Mary J. Ruwart Breakdown of academic impact, for papers by M Armstrong Breakdown of academic impact, for papers by Stéphane Dhalluin Breakdown of academic impact, for papers by Teija Oinonen Breakdown of academic impact, for papers by Sophie Regan Breakdown of academic impact, for papers by Paola Gnocchi Breakdown of academic impact, for papers by M. S. Anwer Breakdown of academic impact, for papers by B. O. Depelchin
Rankless by CCL
2026